Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Bell

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Cardiology|June 1, 2020
Regional variability in Canadian routine care of type 2 diabetes, hypercholesterolemia, and hypertension: Results from the The Cardio-Vascular and metabolic treatments in Canada: Assessment of REal-life therapeutic value (CV-CARE) registryRonald Goldenberg, Alan Bell, Will Cheng, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|September 20, 2019
A call to action to implement prescribing authority to pharmacists for hypertension managementNadia Khan, Alan Bell, Angelique Berg, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 8, 2022
Ups and downs of hypertension control in Canada: critical factors and lessons learnedNorm Rc Campbell, Raj Padwal, Ross T Tsuyuki, et al.
Biomarker Research|April 14, 2018
PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challengeThomas Southworth, Sarah Mason, Alan Bell, et al.
The Canadian Journal of Cardiology|October 9, 2010
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registryKim G Smolderen, Alan Bell, Yang Lei, et al.
CJC Open|July 27, 2023
Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care PracticesRiddhima Dinah Thomas, Leanne Kosowan, Mary Rabey, et al.
Canadian Journal of Diabetes|May 29, 2019
CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical PracticeVincent Woo, Alan Bell, Maureen Clement, et al.
Canadian Journal of Kidney Health and Disease|February 2, 2023
Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary CareDavid Z I Cherney, Alan Bell, Louis Girard, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 23, 2011
New anticoagulants for atrial fibrillation: the beginning of a a new era in stroke preventionDavid J Gladstone, Karen M Earl, Tammy J Bungard, et al.
Archives of Osteoporosis|May 5, 2022
A retrospective observational study of osteoporosis management after a fragility fracture in primary careAlan Bell, David L Kendler, Aliya A Khan, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cardiology|June 1, 2020
Regional variability in Canadian routine care of type 2 diabetes, hypercholesterolemia, and hypertension: Results from the The Cardio-Vascular and metabolic treatments in Canada: Assessment of REal-life therapeutic value (CV-CARE) registryRonald Goldenberg, Alan Bell, Will Cheng, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|September 20, 2019
A call to action to implement prescribing authority to pharmacists for hypertension managementNadia Khan, Alan Bell, Angelique Berg, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 8, 2022
Ups and downs of hypertension control in Canada: critical factors and lessons learnedNorm Rc Campbell, Raj Padwal, Ross T Tsuyuki, et al.
Biomarker Research|April 14, 2018
PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challengeThomas Southworth, Sarah Mason, Alan Bell, et al.
The Canadian Journal of Cardiology|October 9, 2010
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registryKim G Smolderen, Alan Bell, Yang Lei, et al.
CJC Open|July 27, 2023
Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care PracticesRiddhima Dinah Thomas, Leanne Kosowan, Mary Rabey, et al.
Canadian Journal of Diabetes|May 29, 2019
CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical PracticeVincent Woo, Alan Bell, Maureen Clement, et al.
Canadian Journal of Kidney Health and Disease|February 2, 2023
Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary CareDavid Z I Cherney, Alan Bell, Louis Girard, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 23, 2011
New anticoagulants for atrial fibrillation: the beginning of a a new era in stroke preventionDavid J Gladstone, Karen M Earl, Tammy J Bungard, et al.
Archives of Osteoporosis|May 5, 2022
A retrospective observational study of osteoporosis management after a fragility fracture in primary careAlan Bell, David L Kendler, Aliya A Khan, et al.
Pageof 5